A carregar...

Anti-CD33 chimeric antigen receptor targeting of acute myeloid leukemia

Current therapies for acute myeloid leukemia are associated with high failure and relapse rates. Adoptive immunotherapies, which have shown promise in the treatment of hematologic malignancies, have the potential to target acute myeloid leukemia through pathways that are distinct and complementary t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Haematologica
Main Authors: O’Hear, Carol, Heiber, Joshua F., Schubert, Ingo, Fey, Georg, Geiger, Terrence L.
Formato: Artigo
Idioma:Inglês
Publicado em: Ferrata Storti Foundation 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4349272/
https://ncbi.nlm.nih.gov/pubmed/25480499
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2014.112748
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!